Literature DB >> 18481160

Genetic polymorphisms in the CD40 ligand gene and Kawasaki disease.

Fu-Yuan Huang1, Tzu-Yang Chang, Ming-Ren Chen, Nan-Chang Chiu, Hsin Chi, Hung-Chang Lee, Shuan-Pei Lin, Chih-Kai Chen, Hui-Wen Chan, Wei-Fang Chen, Hsin-Fu Liu, Chen-Chung Chu, Marie Lin, Yann-Jinn Lee.   

Abstract

BACKGROUND: Although some previous studies have reported that genetic and immunological factors play important roles in the pathogenesis of Kawasaki disease (KD), the etiological factors of this enigmatical pediatric disease are still poorly understood.
PURPOSE: This study aims to investigate whether polymorphisms of the CD40 ligand (CD40L) gene are associated with KD and the development of coronary artery lesions (CAL) in the Taiwanese children.
MATERIALS AND METHODS: The CD40L -3459 A/G and IVS4+121 A/G single nucleotide polymorphisms (SNPs) were genotyped in 167 children with KD and 1,010 ethnically matched healthy controls by TaqMan assay.
RESULTS: None of the CD40L polymorphisms was associated with susceptibility or CAL development of KD, and this finding was supported by the haplotype analysis.
CONCLUSION: In summary, these results provide little support for specific CD40L SNPs in the susceptibility or CAL development of KD in Taiwanese children. However, it will be necessary to validate or replicate this association in other independent large-size ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18481160     DOI: 10.1007/s10875-008-9203-6

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  35 in total

1.  Nationwide survey of Kawasaki disease and acute rheumatic fever.

Authors:  K A Taubert; A H Rowley; S T Shulman
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

2.  A freely available statistical program for testing associations.

Authors:  Y J Lee; M R Chen; W C Chang; F S Lo; F Y Huang
Journal:  MD Comput       Date:  1998 Sep-Oct

Review 3.  CD40 and its ligand.

Authors:  L B Clark; T M Foy; R J Noelle
Journal:  Adv Immunol       Date:  1996       Impact factor: 3.543

Review 4.  CD40-CD40 ligand.

Authors:  C van Kooten; J Banchereau
Journal:  J Leukoc Biol       Date:  2000-01       Impact factor: 4.962

Review 5.  Diagnosis and therapy of Kawasaki disease in children.

Authors:  A S Dajani; K A Taubert; M A Gerber; S T Shulman; P Ferrieri; M Freed; M Takahashi; F Z Bierman; A W Karchmer; W Wilson
Journal:  Circulation       Date:  1993-05       Impact factor: 29.690

6.  The soluble CD40 ligand sCD154 in systemic lupus erythematosus.

Authors:  K Kato; E Santana-Sahagún; L Z Rassenti; M H Weisman; N Tamura; S Kobayashi; H Hashimoto; T J Kipps
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

7.  Coronary artery caliber in normal children and patients with Kawasaki disease but without aneurysms: an echocardiographic and angiographic study.

Authors:  K Arjunan; S R Daniels; R A Meyer; D C Schwartz; H Barron; S Kaplan
Journal:  J Am Coll Cardiol       Date:  1986-11       Impact factor: 24.094

8.  Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease.

Authors:  M C Nash; V Shah; M J Dillon
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

9.  Impaired T cell-mediated macrophage activation in CD40 ligand-deficient mice.

Authors:  R D Stout; J Suttles; J Xu; I S Grewal; R A Flavell
Journal:  J Immunol       Date:  1996-01-01       Impact factor: 5.422

10.  Chemokines in Kawasaki disease: measurement of CCL2, CCL22 and CXCL10.

Authors:  Yasufumi Shikishima; Toshiaki Saeki; Nobuo Matsuura
Journal:  Asian Pac J Allergy Immunol       Date:  2003-09       Impact factor: 2.310

View more
  10 in total

Review 1.  Genetic polymorphisms in Kawasaki disease.

Authors:  Ho-chang Kuo; Wei-chiao Chang
Journal:  Acta Pharmacol Sin       Date:  2011-09-05       Impact factor: 6.150

2.  Genetic polymorphism of SMAD5 is associated with Kawasaki disease.

Authors:  Ja Hyang Cho; Mi Young Han; Sung Ho Cha; Joo Ho Jung; Kyung Lim Yoon
Journal:  Pediatr Cardiol       Date:  2013-10-26       Impact factor: 1.655

3.  CD40 Gene polymorphisms associated with susceptibility and coronary artery lesions of Kawasaki disease in the Taiwanese population.

Authors:  Ho-Chang Kuo; Mei-Chyn Chao; Yu-Wen Hsu; Ying-Chi Lin; Ying-Hsien Huang; Hong-Ren Yu; Ming-Feng Hou; Chi-Di Liang; Kuender D Yang; Wei-Chiao Chang; Chih-Lu Wang
Journal:  ScientificWorldJournal       Date:  2012-05-02

4.  miRNA-145 inhibits VSMC proliferation by targeting CD40.

Authors:  Xin Guo; Dai Li; Min Chen; Lei Chen; Bikui Zhang; Tian Wu; Ren Guo
Journal:  Sci Rep       Date:  2016-10-12       Impact factor: 4.379

Review 5.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

Review 6.  Preventing coronary artery lesions in Kawasaki disease.

Authors:  Ho-Chang Kuo
Journal:  Biomed J       Date:  2017-05-30       Impact factor: 4.910

Review 7.  The role of infection in Kawasaki syndrome.

Authors:  Nicola Principi; Donato Rigante; Susanna Esposito
Journal:  J Infect       Date:  2013-04-18       Impact factor: 6.072

8.  Lower CMV and EBV Exposure in Children With Kawasaki Disease Suggests an Under-Challenged Immune System.

Authors:  Diana van Stijn-Bringas Dimitriades; Annemarie Slegers; Hans Zaaijer; Taco Kuijpers
Journal:  Front Pediatr       Date:  2021-01-21       Impact factor: 3.418

9.  Interleukin-21 receptor gene polymorphisms in kawasaki disease.

Authors:  Mi Hyun Kim; Yon Jung Bae; Hyun Keun Lee; Yeong Ro Lee; Dong Hoon Lee; Kiho Bae; Sang Baek Koh; Mee Kyung Namgoong; Byung Ho Cha; Hae Yong Lee
Journal:  Korean Circ J       Date:  2013-01-31       Impact factor: 3.243

10.  Validation of genome-wide associated variants for Kawasaki disease in a Taiwanese case-control sample.

Authors:  Ming-Ren Chen; Tzu-Yang Chang; Nan-Chang Chiu; Hsin Chi; Kuender D Yang; Lung Chang; Daniel Tsung-Ning Huang; Fu-Yuan Huang; Ya-Ping Lien; Wen-Shan Lin; Chiung-Ling Lin; Luan-Yin Chang; Yann-Jinn Lee
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.